Vladas Algirdas Bumelis, founder and CEO of JSC Biotechpharma, is one of the leading figures in biotechnology in the Baltics. Now, he is focusing his attention on the construction of three state-of-the-art plants in Lithuania that will house cutting-edge 3D printers that will print cells and even entire body parts. “If I were a biotech entrepreneur from the West, my endeavors wouldn’t impress many. But when pursued in Lithuania, which is better known for its basketball than for anything else, they tend to catch many off-guard,” laughs Bumelis. Listed as one of Northern Eur...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our
SUBSCRIPTION section
